Literature DB >> 4194926

The management of terminal carcinoma with oral potassium permanganate.

G Sokhi.   

Abstract

Oral potassium permanganate has been used in the management of terminal carcinoma in three patients. Symptomatic improvement occurred in all three, with elimination of oral foetor in one patient and diminished requirement of analgesics in the other two. The mental state of each patient was improved and normal activities were resumed.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4194926      PMCID: PMC2008575          DOI: 10.1038/bjc.1970.33

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  2 in total

1.  High-pressure oxygen and radiotherapy.

Authors:  I CHURCHILL-DAVIDSON; C SANGER; R H THOMLINSON
Journal:  Lancet       Date:  1955-05-28       Impact factor: 79.321

2.  Oxygen poisoning in man.

Authors:  K W DONALD
Journal:  Br Med J       Date:  1947-05-17
  2 in total
  2 in total

1.  Metabolic iodine and tumours.

Authors:  D S Robertson
Journal:  Cell Oncol (Dordr)       Date:  2017-10-16       Impact factor: 6.730

2.  Manganese potentiation of autologous anti-Meth A tumor vaccines. A developmental study.

Authors:  D L McCollester
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.